Cargando…

Meta-analysis on Effectiveness and Safety of Moxifloxacin in Treatment of Multidrug Resistant Tuberculosis in Adults

BACKGROUND: Moxifloxacin, a fourth generation fluoroquinolone, which has good antibacterial activity against both Gram-positive cocci and Gram-negative bacteria. To date, there are no meta-analysis to evaluate the efficacy and safety of moxifloxacin for multi-drug resistant tuberculosis (MDR-TB) tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Yanmin, Liu, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	4900
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310829/ https://www.ncbi.nlm.nih.gov/pubmed/32569195 http://dx.doi.org/10.1097/MD.0000000000020648

Ejemplares similares

Pulmonary resection in the treatment of multidrug-resistant tuberculosis: A case series
por: Wang, Lin, et al.
Publicado: (2017)

Comprehensive clinical evaluation of moxifloxacin: A retrospective study
por: Wang, Hailiang, et al.
Publicado: (2023)

Side effects associated with the treatment of multidrug-resistant tuberculosis at a tuberculosis referral hospital in South Korea: A retrospective study
por: Yang, Tae Won, et al.
Publicado: (2017)

Lefamulin vs moxifloxacin for community-acquired bacterial pneumonia
por: Tang, Hung-Jen, et al.
Publicado: (2020)

Clinical study on the safety and efficacy of high-dose tigecycline in the elderly patients with multidrug-resistant bacterial infections: A retrospective analysis
por: Xia, Guolian, et al.
Publicado: (2020)

Time to sputum culture conversion and its predictors among patients with multidrug-resistant tuberculosis in Hangzhou, China: A retrospective cohort study
por: Li, Qingchun, et al.
Publicado: (2020)

Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases: A meta-analysis
por: Gong, Jinhong, et al.
Publicado: (2019)

Effectiveness of tocilizumab in the treatment of hospitalized adults COVID-19: A systematic review and meta-analysis
por: Zhang, Jing, et al.
Publicado: (2022)

Traditional Chinese medicine combined with western medicine for the treatment of secondary pulmonary tuberculosis: A PRISMA-compliant meta-analysis
por: Li, Xiangwen, et al.
Publicado: (2020)

Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis
por: Ni, Wentao, et al.
Publicado: (2016)

Effects and safety of tanreqing injection on viral pneumonia: A protocol for systematic review and meta-analysis
por: Liu, Hui, et al.
Publicado: (2020)

A systematic review and meta-analysis of the efficacy and safety of arbidol in the treatment of coronavirus disease 2019
por: Wang, Xuemei, et al.
Publicado: (2020)

Association between IRGM polymorphisms and tuberculosis risk: A meta-analysis
por: Xie, Haojun, et al.
Publicado: (2017)

Efficacy, safety, and tolerability of a 24-month treatment regimen including delamanid in a child with extensively drug-resistant tuberculosis: A case report and review of the literature
por: Esposito, Susanna, et al.
Publicado: (2016)

Efficacy and safety of Lianhua Qingwen in the treatment of patients with moderate COVID-19 infection: A protocol for systematic review and meta analysis
por: Liu, Nanyang, et al.
Publicado: (2020)

High prevalence of multidrug-resistant gram-negative bacterial infection following pediatric liver transplantation
por: Phichaphop, Chanita, et al.
Publicado: (2020)

Efficacy and safety of Shufeng Jiedu capsule in the treatment of COVID-19: A protocol for systematic review and meta analysis
por: Ma, Li, et al.
Publicado: (2020)

Efficacy and safety of chloroquine and hydroxychloroquine in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis
por: Liu, Yan, et al.
Publicado: (2020)

Monokine induced by gamma interferon for detecting pulmonary tuberculosis: A diagnostic meta-analysis
por: Li, Yang, et al.
Publicado: (2020)

Interleukin-4 expression is increased in patients with tuberculosis: A systematic review and meta-analysis
por: He, Jie, et al.
Publicado: (2023)

The efficacy and safety of omadacycline in treatment of acute bacterial infection: A systemic review and meta-analysis of randomized controlled trials
por: Lan, Shao-Huan, et al.
Publicado: (2019)

Efficacy and safety of DPP-4 inhibitor in the treatment of patients with COVID-19 combined with diabetes mellitus: A protocol for systematic review and meta-analysis
por: Liu, Yan, et al.
Publicado: (2020)

A systematic review and meta-analysis of the efficacy and safety of western medicine routine treatment combined with Chinese herbal medicine in the treatment of COVID-19
por: Wang, Xuemei, et al.
Publicado: (2020)

Retrospective Comparison of Levofloxacin and Moxifloxacin on Multidrug-Resistant Tuberculosis Treatment Outcomes
por: Lee, Jinwoo, et al.
Publicado: (2011)

Vitamin D Receptor Gene FokI Polymorphism Contributes to Increasing the Risk of Tuberculosis: An Update Meta-Analysis
por: Huang, Liling, et al.
Publicado: (2015)

Diagnostic value of microRNA-155 in active tuberculosis: A systematic review and meta-analysis
por: Li, Xiaoyan, et al.
Publicado: (2021)

Efficacy and safety of Qi and Blood Tonic Chinese Medicines in the treatment of COVID-19: A protocol for systematic review and meta-analysis
por: Yang, Feifei, et al.
Publicado: (2022)

A protocol for systematic review and meta-analysis of optimizing treatment for malaria
por: Zhang, Renyan, et al.
Publicado: (2020)

Efficacy of Xpert MTB/RIF Ultra in diagnosing tuberculosis meningitis: A systematic review and meta-analysis
por: Shen, Yanqin, et al.
Publicado: (2021)

Bacteremic Urinary Tract Infection Caused by Multidrug-Resistant Enterobacteriaceae Are Associated With Severe Sepsis at Admission: Implication for Empirical Therapy
por: Lee, Yi-Chien, et al.
Publicado: (2016)

The efficacy and safety of fire needle therapy for COVID-19: Protocol for a systematic review and meta-analysis
por: Liu, Min, et al.
Publicado: (2020)

Effect of pharmaceutical care on the treatment of COVID-19: A protocol for systematic review and meta analysis
por: Niu, Jiali, et al.
Publicado: (2020)

Assessment of the efficacy and safety of Ribavirin in treatment of coronavirus-related pneumonia (SARS, MERS and COVID-19): A protocol for systematic review and meta-analysis
por: Wang, Yinhua, et al.
Publicado: (2020)

Mycobacterium culturing and drug resistance of osteoarticular tuberculosis in Xinjiang, China
por: Hajiaheman, Yeerzati, et al.
Publicado: (2020)

Diagnostic significance of long non-coding RNAs expression in tuberculosis patients: A systematic review and meta-analysis
por: Zhong, Xiaoling, et al.
Publicado: (2022)

Efficacy and safety of Shufeng Jiedu capsule for coronavirus disease 2019 (COVID-19): A protocol for systematic review and meta-analysis
por: Li, Runmin, et al.
Publicado: (2020)

The epidemiological characteristics and profile of drug-resistant tuberculosis among children with tuberculosis in Sichuan, China, 2015–2018: A retrospective study
por: Xu, Yuanhong, et al.
Publicado: (2020)

Efficacy and safety of cefoperazone-sulbactam in empiric therapy for febrile neutropenia: A systemic review and meta-analysis
por: Lan, Shao-Huan, et al.
Publicado: (2020)

The effectiveness and safety of traditional Chinese medicine for the treatment of children with COVID-19
por: Li, Yanqing, et al.
Publicado: (2020)

Epidemiological Trends of Drug-Resistant Tuberculosis in China From 2007 to 2014: A Retrospective Study
por: He, Xiao-chun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4bpccj3k28m8ua2kpt53056376